Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes

Amyloid

Volumn 20, Issue 2, 2013, Pages 122-126

  Mereuta, Oana M ^a   Baldovino, Simone ^a   Errichiello, Edoardo ^b   Binello, Giovanni B ^a   Restagno, Gabriella ^b   Battaglia, Giovanni G ^c   Mazzucco, Gianna ^d   Roccatello, Dario ^a  

^a S GIOVANNI BOSCO HOSPITAL   (Italy)

^b ASO OIRM S Anna   (Italy)

^c Ospedale Santa Marta e Santa Venera   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Autoinflammatory syndromes; DNA sequencing; Nephrotic syndrome; Secondary amyloidosis; Serum amyloid A protein

Indexed keywords

SERUM AMYLOID A; TUMOR NECROSIS FACTOR RECEPTOR 1;

ABDOMINAL PAIN; ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEVER; FLUORESCENCE MICROSCOPY; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; IMMUNOFLUORESCENCE; LEG EDEMA; MALE; MEDITERRANEAN FEVER GENE; NEPHROTIC SYNDROME; PREGNANCY; PRIORITY JOURNAL;

ADULT; AMYLOIDOSIS; CYTOSKELETAL PROTEINS; FEMALE; GENETIC TESTING; HETEROZYGOTE; HUMANS; MUTATION; NEPHROTIC SYNDROME; POLYMORPHISM, GENETIC; PREGNANCY; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; YOUNG ADULT;

EID: 84878280621     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2013.775119     Document Type: Article

References (17)

1. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalcinkaya F, et al. Country as the primary risk factor for renal amyloidosis in Familial Mediterranean Fever. Arthritis Rheum 2007;56:1706-12.
2. Dode C, Hazenberg B, Pecheux C, Cattan D, Moulin B, Barthelemy A, Gubler MC, et al. Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks. Nephrol Dial Transplant 2002;17: 1212-17.
3. Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 2001;69:301-14.
4. Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoin-flammatory disorder. Medicine (Baltimore) 2002;81:349-68.
5. Masson C, Simon V, Hoppe E, Insalaco P, Cisse I, Audran M. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine 2004;71:284-90.
6. Ravet N, Rouaghe S, Dode C, Bienvenu J, Stirnemann J, Levy P, Delpech M, Grateau G. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis 2006;65:1158-62.
7. Aganna E, Hawkins PN, Ozen S, Pettersson T, Bybee A, McKee SA, Lachmann HJ, et al. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun 2004;5:289-93.
8. Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet 2001;9:473-83.
9. Cigni A, Ledda F, Satta AE. A complex case of renal amyloidosis with a rare co-occurrence of 2 mutations in separate hereditary periodic fever syndrome-related genes. J Nephrol 2006;19:543-9.
10. Granel B, Serratrice J, Dode C, Grateau G, Disdier P, Weiller PJ. Overlap syndrome between FMF and TRAPS in a patient carrying MEFV and TNFRSF1A mutations. Clin Exp Rheumatol 2007;25: 93-5.
11. Cantarini L, Baldari CT, Rossi Paccani S, Lucherini OM, Laghi Pasini F, Galeazzi M. Saturday night fever: bizarre recurrence of fever attacks in a patient carrying a mutation in both the MEFV and TNFRSF1A genes. Clin Exp Rheumatol 2008;26:128-9.
12. Stojanov S, Lohse P, Lohse P, Hoffmann F, Renner ED, Zellerer S, Kery A, et al. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum 2004; 50:1951-8.
13. Hoffmann F, Lohse P, Stojanov S, Shin YS, Renner ED, Kery A, Zellerer S, Belohradsky BH. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation. Eur J Hum Genet 2005;13:510-12.
14. Arkwright PD, McDermott MF, Houten SM, Frenkel J, Waterham HR, Aganna E, Hammond LJ, et al. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept. Clin Exp Immunol 2002;130:484-8.
15. Singh-Grewal D, Chaitow J, Aksentijevich I, Christodoulou J. Coexistent MEFV and CIAS1 mutations manifesting as familial Mediterranean fever plus deafness. Ann Rheum Dis 2007;66:1541.
16. Marek-Yagel D, Berkun Y, Padeh S, Lidar M, Shinar Y, Bar-Joseph I, Reznik-Wolf H, et al. Role of the R92Q TNFRSF1A mutation in patients with Familial Mediterranean Fever. Arthritis Care Res 2010;62:1294-8.
17. Kovacevic A, Hammer A, Sundl M, Pfister B, Hrzenjak A, Ray A, Ray BK, et al. Expression of serum amyloid A transcripts in human trophoblast and fetal-derived trophoblast-like choriocarcinoma cells. FEBS Lett 2006;580:161-7.